GE HealthCare Technologies (NASDAQ:GEHC) Given New $88.00 Price Target at BNP Paribas Exane

GE HealthCare Technologies (NASDAQ:GEHC) had its target price lowered by BNP Paribas Exane from $95.00 to $88.00 in a report released on Friday,MarketScreener reports.

Other equities analysts have also recently issued research reports about the stock. Piper Sandler decreased their price target on shares of GE HealthCare Technologies from $96.00 to $88.00 and set an “overweight” rating for the company in a research report on Friday, April 17th. Citigroup dropped their price target on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research note on Thursday. Wells Fargo & Company dropped their price target on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research note on Thursday. The Goldman Sachs Group downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $81.00 to $65.00 in a research note on Thursday. Finally, Morgan Stanley boosted their price target on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th. Eight analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $82.00.

GE HealthCare Technologies Trading Down 0.0%

Shares of NASDAQ:GEHC traded down $0.03 during mid-day trading on Friday, reaching $61.00. 7,798,471 shares of the company were exchanged, compared to its average volume of 4,033,638. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The firm has a market cap of $27.75 billion, a price-to-earnings ratio of 14.59, a P/E/G ratio of 1.37 and a beta of 0.75. The firm’s 50-day simple moving average is $73.28 and its 200 day simple moving average is $77.60. GE HealthCare Technologies has a 1 year low of $58.75 and a 1 year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities research analysts forecast that GE HealthCare Technologies will post 4.88 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is 3.35%.

Insider Buying and Selling

In related news, insider Frank R. Jimenez purchased 1,750 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The shares were purchased at an average cost of $60.45 per share, for a total transaction of $105,787.50. Following the purchase, the insider directly owned 93,932 shares of the company’s stock, valued at $5,678,189.40. The trade was a 1.90% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO James Saccaro purchased 3,310 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The shares were bought at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the completion of the purchase, the chief financial officer directly owned 87,471 shares in the company, valued at $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 9,229 shares of company stock worth $556,180 in the last ninety days. 0.36% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On GE HealthCare Technologies

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Western Wealth Management LLC raised its stake in GE HealthCare Technologies by 2.4% during the 4th quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock worth $430,000 after acquiring an additional 125 shares in the last quarter. United Community Bank raised its stake in GE HealthCare Technologies by 10.2% during the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock worth $116,000 after acquiring an additional 130 shares in the last quarter. Parkside Financial Bank & Trust increased its stake in GE HealthCare Technologies by 3.9% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company’s stock valued at $293,000 after purchasing an additional 134 shares during the period. Thoma Capital Management LLC increased its stake in GE HealthCare Technologies by 1.4% in the fourth quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock valued at $814,000 after purchasing an additional 136 shares during the period. Finally, Klingman & Associates LLC increased its stake in GE HealthCare Technologies by 4.0% in the third quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock valued at $273,000 after purchasing an additional 139 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.